EUVIMEDEUVIMED entdecken
Crossref

Pharmacological effects of biologically synthesized ginsenoside CK-rich preparation (AceCK40) on the colitis symptoms in DSS-induced Caco-2 cells and C57BL mice

Hoon Kim, Eun-Jin Jeong, Byungdoo Hwang, Hak-Dong Lee, Sanghyun Lee, Mi Jang, Kwangeun Yeo, Yunjeong Shin, Sanghoon Park, Wan Taek Lim, Woo Jung Kim, Sung-Kwon Moon

Phytomedicine · 2024

DOI: 10.1016/j.phymed.2023.155301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024. Verfasst von Hoon Kim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food and Nutrition, Chung-Ang University, Anseong 17546, South Korea. Hauptthemen laut MEDLINE: Ginsenosides, Colitis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Research Foundation of Korea, Ministry of Education, Ministry of Agriculture, Food and Rural Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Despite the notable pharmacological potential of natural ginsenosides, their industrial application is hindered by low oral bioavailability. Recent research centers on the production of less-glycosylated minor ginsenosides. PURPOSE: This study aimed to explore the effect of a biologically synthesized ginsenoside CK-rich minor ginsenoside complex (AceCK40), on ameliorating colitis using DSS-induced colitis models in vitro and in vivo. METHODS: The ginsenoside composition of AceCK40 was determined by HPLC-ELSD and UHPLC-MS/MS analyses. In vitro colitis model was established using dextran sodium sulfate (DSS)-induced Caco-2 intestinal epithelial model. For in vivo experiments, DSS-induced severe colitis mouse model was established. RESULTS: In DSS-stimulated Caco-2 cells, AceCK40 downregulated mitogen-activated protein kinase (MAPK) activation (p 36.0% decrease, p 37.6% increase, p 33.8% increase, p 65.7% decrease, p 116.2% decrease, p 51.4% increase, p < 0.001) and lowered serum IL-6 (112.3% decrease at 30 mg/kg, p < 0.001). Hematoxylin and eosin (H&E) and periodic acid-Schiff (PAS) staining revealed that DSS-mediated thickening of the muscular externa, extensive submucosal edema, crypt distortion, and decreased mucin droplets were significantly alleviated by AceCK40 administration. Additionally, daily administration of AceCK40 led to significant recovery of colonic tight junctions damaged by DSS through the elevation in the expression of adhesion molecules, including occludin, E-cadherin, and N-cadherin. CONCLUSION: This study presents the initial evidence elucidating the anti-colitis effects of AceCK40 and its underlying mechanism of action through sequential in vitro and in vivo systems employing DSS stimulation. Our findings provide valuable fundamental data for the utilization of AceCK40 in the development of novel anti-colitis candidates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GinsenosidesColitisHumansMiceAnimalsCaco-2 CellsMice, Inbred C57BLTandem Mass SpectrometryColonImmunoglobulin ADextran SulfateDisease Models, AnimalIntestinal Mucosa

Stichwörter der Autor:innen

Enzymatic bioconversionInflammatory bowel diseaseInflammatory cytokineIntestinal barrierMinor ginsenosideSynthetic biology

Substanzen

GinsenosidesImmunoglobulin ADextran Sulfateginsenoside compound K

Autor:innen und Institutionen

  • Department of Food and Nutrition, Chung-Ang University, Anseong 17546, South Korea.
  • Department of Integrated Biomedical and Life Sciences, Korea University, Seoul 02841, South Korea.
  • Department of Plant Science and Technology, Chung-Ang University, Anseong 17546, South Korea.
  • The Food Industry Promotional Agency of Korea, Iksan, South Korea.
  • Research Institute, AceEMzyme, Anseong, South Korea.
  • Biocenter, Gyeonggido Business and Science Accelerator, Suwon 16229, South Korea.

Förderung

  • National Research Foundation of Korea
  • Ministry of Education
  • Ministry of Agriculture, Food and Rural Affairs
  • Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries

Zitieren

APA

Kim, H., Jeong, E. J., Hwang, B., Lee, H. D., Lee, S., Jang, M., Yeo, K., Shin, Y., Park, S., Lim, W. T., Kim, W. J., & Moon, S. K. (2024). Pharmacological effects of biologically synthesized ginsenoside CK-rich preparation (AceCK40) on the colitis symptoms in DSS-induced Caco-2 cells and C57BL mice. Phytomedicine. https://doi.org/10.1016/j.phymed.2023.155301

Vancouver

Kim H, Jeong EJ, Hwang B, Lee HD, Lee S, Jang M, et al. Pharmacological effects of biologically synthesized ginsenoside CK-rich preparation (AceCK40) on the colitis symptoms in DSS-induced Caco-2 cells and C57BL mice. Phytomedicine. 2024. doi:10.1016/j.phymed.2023.155301

BibTeX
@article{Kim2024,
  author = {Kim, Hoon and Jeong, Eun-Jin and Hwang, Byungdoo and Lee, Hak-Dong and Lee, Sanghyun and Jang, Mi and Yeo, Kwangeun and Shin, Yunjeong and Park, Sanghoon and Lim, Wan Taek and Kim, Woo Jung and Moon, Sung-Kwon},
  title = {Pharmacological effects of biologically synthesized ginsenoside CK-rich preparation (AceCK40) on the colitis symptoms in DSS-induced Caco-2 cells and C57BL mice},
  journal = {Phytomedicine},
  year = {2024},
  doi = {10.1016/j.phymed.2023.155301}
}
Kostenlos starten →